These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23793764)

  • 41. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions.
    Yonou H; Ochiai A; Goya M; Kanomata N; Hokama S; Morozumi M; Sugaya K; Hatano T; Ogawa Y
    Prostate; 2004 Mar; 58(4):406-13. PubMed ID: 14968441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment.
    Chirgwin JM; Guise TA
    J Cell Biochem; 2007 Dec; 102(6):1333-42. PubMed ID: 17907152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast cancer bone metastasis: molecular basis of tissue tropism.
    Kang Y
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):379-80. PubMed ID: 15758269
    [No Abstract]   [Full Text] [Related]  

  • 44. [Diagnostic imaging of skeletal metastases].
    Koizumi M; Koyama M
    Clin Calcium; 2006 Apr; 16(4):573- 80. PubMed ID: 16582507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
    Corey E; Brown LG; Quinn JE; Poot M; Roudier MP; Higano CS; Vessella RL
    Clin Cancer Res; 2003 Jan; 9(1):295-306. PubMed ID: 12538482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scope and value of bone marrow biopsies in metastatic cancer.
    Frisch B; Bartl R; Mahl G; Burkhardt R
    Invasion Metastasis; 1984; 4 Suppl 1():12-30. PubMed ID: 6533096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelins in bone cancer metastases.
    Guise TA; Mohammad KS
    Cancer Treat Res; 2004; 118():197-212. PubMed ID: 15043194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Translational models of prostate cancer bone metastasis.
    Berish RB; Ali AN; Telmer PG; Ronald JA; Leong HS
    Nat Rev Urol; 2018 Jul; 15(7):403-421. PubMed ID: 29769644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preclinical models that illuminate the bone metastasis cascade.
    van der Horst G; van der Pluijm G
    Recent Results Cancer Res; 2012; 192():1-31. PubMed ID: 22307368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications.
    Zheng H; Li W; Kang Y
    Cold Spring Harb Symp Quant Biol; 2016; 81():151-161. PubMed ID: 28381439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rat models of bone metastases.
    Blouin S; Baslé MF; Chappard D
    Clin Exp Metastasis; 2005; 22(8):605-14. PubMed ID: 16670964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of lysosomal and further gene expression characterization in lung cancer patients with bone metastasis.
    Huang Y; Chu T; Liao T; Hu X; Huang B
    Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):758-764. PubMed ID: 27683953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor bone diseases: molecular mechanisms and opportunities for novel treatments.
    Susa M; Glatt M; Teti A
    Curr Med Chem Anticancer Agents; 2001 Nov; 1(3):313-29. PubMed ID: 12678761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials.
    Gdowski AS; Ranjan A; Vishwanatha JK
    J Exp Clin Cancer Res; 2017 Aug; 36(1):108. PubMed ID: 28800754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone metastasis: pathogenesis and therapeutic implications.
    Clezardin P; Teti A
    Clin Exp Metastasis; 2007; 24(8):599-608. PubMed ID: 18008175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference.
    Lipton A; Berenson JR; Body JJ; Boyce BF; Bruland OS; Carducci MA; Cleeland CS; Clohisy DR; Coleman RE; Cook RJ; Guise TA; Pearse RN; Powles TJ; Rogers MJ; Roodman GD; Smith MR; Suva LJ; Vessella RL; Weilbaecher KN; King L
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6209s-6212s. PubMed ID: 17062702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An approach for the identification of targets specific to bone metastasis using cancer genes interactome and gene ontology analysis.
    Vashisht S; Bagler G
    PLoS One; 2012; 7(11):e49401. PubMed ID: 23166660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translational Strategies to Target Metastatic Bone Disease.
    Pagnotti GM; Trivedi T; Mohammad KS
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Biology of metastases and molecular mechanisms of their formation].
    Coussy F; Bonin F; Azorin P; Tariq Z; Driouch K
    Bull Cancer; 2019 Jan; 106(1):24-36. PubMed ID: 30554635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Bone metastases].
    Vicent S; Luis-Ravelo D; Antón I; Hernández I; Martínez S; de las Rivas J; Gúrpide A; Lecanda F
    An Sist Sanit Navar; 2006; 29(2):177-88. PubMed ID: 17001355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.